Carboplatin chemotherapy for lung cancer
[DOCX File]Australian public assessment report forAtezolizumab
https://info.5y1.org/carboplatin-chemotherapy-for-lung-cancer_1_c43c08.html
West, H. et al. Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial.
NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE
Lung cancer falls into 2 main histological categories: around 85–90% are non-small-cell lung cancers (NSCLC) and the remainder are small cell lung cancers1,2. NSCLC can be further classified into 3 main histological sub-types of large-cell undifferentiated carcinoma, squamous cell carcinoma and adenocarcinoma.
[DOC File]Treatment of Metastatic Non-Small Cell Lung Cancer: A ...
https://info.5y1.org/carboplatin-chemotherapy-for-lung-cancer_1_b7a958.html
But, if you had lung cancer, that is the kind that you would want to have. Michael Kelley: Paul, I am pretty sure you do not smoke. You are – I think I met you at least once. You are probably older than 45. The chances of you having an EGFR mutant lung cancer would probably be much higher than one percent even though you are in the VA.
[DOC File]LUNG CANCER - cnaZone
https://info.5y1.org/carboplatin-chemotherapy-for-lung-cancer_1_18ad4f.html
Chemotherapy for lug cancer uses IV infusions of a platinum-based drug combined with other chemotherapy drugs: either cisplatin or carboplatin are the platinum-based drugs that are typically used. These drugs along with the other chemotherapeutic agents kill cancer cells and they also stop them from growing.
[DOC File]Lung Cancer
https://info.5y1.org/carboplatin-chemotherapy-for-lung-cancer_1_33d129.html
Smoking is the number one cause of lung cancer. Smoking tobacco is linked to small cell carcinoma, Squamous cell carcinoma and large cell carcinoma ... For extensive disease- single agent or combination chemotherapy such as etoposide plus cisplatin or carboplatin. Remission is short lived. Chemotherapy.
[DOCX File]Registration status - Pharmaceutical Benefits Scheme (PBS)
https://info.5y1.org/carboplatin-chemotherapy-for-lung-cancer_1_0d2bf1.html
The submission requested a Section 100 (Efficient Funding of Chemotherapy Program), Authority Required (STREAMLINED) listing for atezolizumab for the treatment of previously untreated patients with extensive stage (ES) small cell lung cancer (SCLC) and Eastern Cooperative Oncology Group (ECOG) 0-1.
[DOCX File]American Society of Clinical Oncology | ASCO
https://info.5y1.org/carboplatin-chemotherapy-for-lung-cancer_1_a35f77.html
ASCO Treatment Summary and Survivorship Care Plan for Non-Small Cell Lung Cancer . This Survivorship Care Plan is a cancer treatment summary and follow-up plan and is provided to you to keep with your health care records and to share with your primary care provider or any of your doctors and nurses.
[DOCX File]Future Science | Home
https://info.5y1.org/carboplatin-chemotherapy-for-lung-cancer_1_cd7670.html
A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861. J Clin Oncol. 1990;8(9):1556-62.
[DOC File]Pemetrexed Maintenance Therapy Significantly Improves PFS ...
https://info.5y1.org/carboplatin-chemotherapy-for-lung-cancer_1_233d6f.html
Lung Cancer. 2006;52:155-163. 3. Fidias PM, Dakhil SR, Lyss AP, et al. Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer. J Clin Oncol. 2009;27:591-598. 4. Hanna N, Shepherd FA, Fossella FV, et al. Randomized phase III trial of ...
[DOC File](Note: The following description is taken from Emerson and ...
https://info.5y1.org/carboplatin-chemotherapy-for-lung-cancer_1_10cfa4.html
non-small cell lung cancer, which is comprised of squamous cell cancer, adenocarcinoma (arising from glandular cells), and large cell cancer (which is possibly derived from squamous cells, though a subtype attributed to a neuroendocrine origin also exists). The treatment of SCLC is typically radiation and chemotherapy, and the prognosis for ...
[DOC File]ATLAS: Improved PFS With Addition of Erlotinib to ...
https://info.5y1.org/carboplatin-chemotherapy-for-lung-cancer_1_70a653.html
4. Herbst RS, O'Neill VJ, Fehrenbacher L, et al. Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer. J Clin Oncol. 2007;25:4743-4750. 5. Hainsworth J, Lin M, O’Connor P, et al.
[DOC File]Pharmacology—Chemotherapy and Supportive Care
https://info.5y1.org/carboplatin-chemotherapy-for-lung-cancer_1_239415.html
Cancers of the lung, prostate, and breast and of the colon and rectum account for about 55% of all new cancer diagnoses and for over 50% of cancer deaths in the US. Currently – Lung cancer is the leading cause of cancer death in the US, accounting for 31% of deaths in men and 27% of deaths in women. Carcinogenesis and Cell Proliferation
[DOCX File]Previous PBAC considerations
https://info.5y1.org/carboplatin-chemotherapy-for-lung-cancer_1_2502a5.html
Subsequent to the July 2019 PBAC meeting, atezolizumab has been TGA registered with the following indication: atezolizumab ‘in combination with carboplatin and etoposide, is indicated for the first-line treatment of patients with extensive-stage small cell lung cancer (ES-SCLC)’.
Nearby & related entries:
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.